ONCS Insider Trading Activity and SEC Form 4 Filings
ONCS insider trading summary
No open-market insider purchases or sales of ONCOSEC MEDICAL Inc (ONCS) have been reported on SEC Form 4 in the past 12 months.
Latest ONCS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 9, 2023 | Robert J DelAversano | VP, Finance | Sell | $55 (40 @ $1.37) |
| Nov 4, 2022 | Robert J DelAversano | VP, Finance | Sell | $105 (283 @ $0.37) |
| Aug 5, 2022 | Robert J DelAversano | VP, Finance | Sell | $202 (284 @ $0.71) |
| May 6, 2022 | Robert J DelAversano | VP, Finance | Sell | $227 (274 @ $0.83) |
| Feb 9, 2022 | Robert J DelAversano | VP, Finance | Sell | $360 (409 @ $0.88) |
| Nov 1, 2021 | Robert J DelAversano | VP, Finance | Sell | $600 (343 @ $1.75) |
| Aug 23, 2021 | Margaret Dalesandro | Director | Buy | $38K (20,000 @ $1.89) |
| Aug 23, 2021 | Yuhang Zhao | Director | Buy | $8K (4,000 @ $1.88) |
| Aug 20, 2021 | Yuhang Zhao | Director | Buy | $16K (8,000 @ $1.94) |
| Aug 2, 2021 | Robert J DelAversano | VP, Finance | Sell | $898 (412 @ $2.18) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.